Search results
FDA advisory panel recommends new Alzheimer's drug after scrutiny
UPI· 6 days agoA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the...
Dementia drug wins panel OK | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 7 days agoFood and Drug Administration advisers voted unanimously that the drug's ability to slow the disease...
State abortion bans forcing interstate travel, U.S. Senate panel hears
Michigan Advance via Yahoo News· 8 hours agoWASHINGTON — When Lauren Miller flew from her home state of Texas to Colorado two years ago she felt...
Teen Vogue's 2024 Generation Next: Enter Now and Meet The Judges
Teen Vogue via Yahoo News· 10 hours agoSubmissions for designers looking to get their start in the fashion industry are now open. Our goal...
FDA panel backs Alzheimer's drug that can reportedly slow cognitive decline
AOL· 6 days agoA panel of federal health advisers is recommending that the U.S. Food and Drug Administration...
US health advisers back drug to slow Alzheimer's disease
Euronews via Yahoo News· 6 days agoA panel of advisers to US health regulators backed a drug to slow Alzheimer's disease on Monday...
Lilly Endowment sells Eli Lilly shares worth over $13 million By Investing.com
Investing.com· 3 hours agoLilly Endowment Inc., a major shareholder in Eli Lilly & Co (NYSE:LLY), has executed a significant...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 2 hours agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
US medical advisers vote to recommend Eli Lilly Alzheimer drug
Medical Xpress· 7 days agoAn independent panel of US medical experts voted Monday to recommend Eli Lilly's experimental Alzheimer's drug, meaning there could soon be another treatment option available ...
Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers
Fortune· 7 days agoFood and Drug Administration advisers voted unanimously that the drug’s ability to slow the disease outweighs its risks, including side effects like brain swelling and bleeding ...